Nov 24 2010

Updating the progress of Argos’ dendritic cell immunotherapies in development to treat cancer, infectious and autoimmune diseases


Guest: Jeffrey Abbey, President & CEO, Argos Therapeutics, Inc., Durham, NC

abbey2010photo.jpg
Jeffrey Abbey, President & CEO, Argos Therapeutics, Inc., Durham

Argos Therapeutics, Inc.

Advertisement

Leave a Reply

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out /  Change )

Cancel

Connecting to %s